Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지
DOI QR코드

DOI QR Code

Patterns of initial failure after resection for gallbladder cancer: implications for adjuvant radiotherapy

  • Kim, Tae Gyu (Department of Radiation Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine)
  • Received : 2017.08.11
  • Accepted : 2017.10.10
  • Published : 2017.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: This study sought to identify potential candidates for adjuvant radiotherapy and patterns of regional failure in patients who underwent curative-intent surgery for gallbladder cancer. Materials and Methods: Records for 70 patients with gallbladder cancer who underwent curative resection at a single institution between 2000 and 2016 were analysed retrospectively. No patients received adjuvant radiotherapy. Initial patterns of failure were evaluated. Regional recurrence was categorized according to the definitions of lymph node stations suggested by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. Results: Median follow-up was 23 months. Locoregional recurrence as any component of first failure occurred in 29 patients (41.4%), with isolated locoregional recurrence in 13 (18.6%). Regional recurrence occurred in 23 patients, and 77 regional recurrences were identified. Commonly involved regional stations were #13, #12a2, #12p2, #12b2, #16a2, #16b1, #9, and #8. Independent prognostic factors for locoregional recurrence were ${\geq}pT2$ disease (hazard ratio [HR], 5.510; 95% confidence interval [CI], 1.260-24.094; p = 0.023) and R1 resection (HR, 6.981; 95% CI, 2.378-20.491; p < 0.001). Conclusion: Patients with pT2 disease or R1 resection after curative surgery for gallbladder cancer may benefit from adjuvant radiotherapy. Our findings on regional recurrence may help physicians construct a target volume for adjuvant radiotherapy.

Keywords

References

  1. Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol 2014;6:99-109.
  2. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006;118:1591-602. https://doi.org/10.1002/ijc.21683
  3. Miller G, Jarnagin WR. Gallbladder carcinoma. Eur J Surg Oncol 2008;34:306-12. https://doi.org/10.1016/j.ejso.2007.07.206
  4. Fong Y, Wagman L, Gonen M, et al. Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database. Ann Surg 2006;243:767-74. https://doi.org/10.1097/01.sla.0000219737.81943.4e
  5. Lee SE, Kim KS, Kim WB, et al. Practical guidelines for the surgical treatment of gallbladder cancer. J Korean Med Sci 2014;29:1333-40. https://doi.org/10.3346/jkms.2014.29.10.1333
  6. Sikora SS, Singh RK. Surgical strategies in patients with gallbladder cancer: nihilism to optimism. J Surg Oncol 2006;93:670-81. https://doi.org/10.1002/jso.20535
  7. Abramson MA, Pandharipande P, Ruan D, Gold JS, Whang EE. Radical resection for T1b gallbladder cancer: a decision analysis. HPB (Oxford) 2009;11:656-63. https://doi.org/10.1111/j.1477-2574.2009.00108.x
  8. Margonis GA, Gani F, Buettner S, et al. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium. HPB (Oxford) 2016;18:872-8. https://doi.org/10.1016/j.hpb.2016.05.016
  9. Mallick S, Benson R, Haresh KP, Julka PK, Rath GK. Adjuvant radiotherapy in the treatment of gall bladder carcinoma: what is the current evidence. J Egypt Natl Canc Inst 2016;28:1-6. https://doi.org/10.1016/j.jnci.2015.07.004
  10. Itoh H, Nishijima K, Kurosaka Y, et al. Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder. Dig Dis Sci 2005;50:2231-42. https://doi.org/10.1007/s10620-005-3040-8
  11. Park HS, Lim JY, Yoon DS, et al. Outcome of adjuvant therapy for gallbladder cancer. Oncology 2010;79:168-73. https://doi.org/10.1159/000322914
  12. Glazer ES, Liu P, Abdalla EK, Vauthey JN, Curley SA. Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins. J Gastrointest Surg 2012;16:1666-71. https://doi.org/10.1007/s11605-012-1935-1
  13. Williams TM, Majithia L, Wang SJ, Thomas CR Jr. Defining the role of adjuvant therapy: cholangiocarcinoma and gall bladder cancer. Semin Radiat Oncol 2014;24:94-104. https://doi.org/10.1016/j.semradonc.2014.01.001
  14. Gold DG, Miller RC, Haddock MG, Gunderson LL, Quevedo F, Donohue JH, Bhatia S, Nagorney DM. Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience. Int J Radiat Oncol Biol Phys 2009;75:150-5. https://doi.org/10.1016/j.ijrobp.2008.10.052
  15. Wang SJ, Fuller CD, Kim JS, Sittig DF, Thomas CR Jr, Ravdin PM. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol 2008;26:2112-7. https://doi.org/10.1200/JCO.2007.14.7934
  16. Kim MY, Kim JH, Kim Y, Byun SJ. Postoperative radiotherapy appeared to improve the disease free survival rate of patients with extrahepatic bile duct cancer at high risk of loco-regional recurrence. Radiat Oncol J 2016;34:297-304. https://doi.org/10.3857/roj.2016.01879
  17. Miyazaki M, Ohtsuka M, Miyakawa S, et al. Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition. J Hepatobiliary Pancreat Sci 2015;22:181-96. https://doi.org/10.1002/jhbp.211
  18. Jarnagin WR, Ruo L, Little SA, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer 2003;98:1689-700. https://doi.org/10.1002/cncr.11699
  19. Jung SJ, Woo SM, Park HK, et al. Patterns of initial disease recurrence after resection of biliary tract cancer. Oncology 2012;83:83-90. https://doi.org/10.1159/000339695
  20. Kim WS, Choi DW, You DD, Ho CY, Heo JS, Choi SH. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma. J Gastrointest Surg 2010;14:679-87. https://doi.org/10.1007/s11605-009-1140-z
  21. Ben-Josef E, Guthrie KA, El-Khoueiry AB, et al. SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma. J Clin Oncol 2015;33:2617-22. https://doi.org/10.1200/JCO.2014.60.2219
  22. Jeong Y, Park JH, Lee YJ, et al. Postoperative radiotherapy for gallbladder cancer. Anticancer Res 2014;34:5621-9.
  23. Mojica P, Smith D, Ellenhorn J. Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease. J Surg Oncol 2007;96:8-13. https://doi.org/10.1002/jso.20831
  24. Mitin T, Enestvedt CK, Jemal A, Sineshaw HM. Limited use of adjuvant therapy in patients with resected gallbladder cancer despite a strong association with survival. J Natl Cancer Inst 2017;109:djw324.
  25. Mantripragada KC, Hamid F, Shafqat H, Olszewski AJ. Adjuvant therapy for resected gallbladder cancer: analysis of the National Cancer Data Base. J Natl Cancer Inst 2016;109:djw202.
  26. Bae JS, Kim DH, Kim WT, Kim YH, Park D, Ki YK. The role of surgical clips in the evaluation of interfractional uncertainty for treatment of hepatobiliary and pancreatic cancer with postoperative radiotherapy. Radiat Oncol J 2017;35:65-70. https://doi.org/10.3857/roj.2016.02019
  27. Sun XN, Wang Q, Gu BX, et al. Adjuvant radiotherapy for gallbladder cancer: a dosimetric comparison of conformal radiotherapy and intensity-modulated radiotherapy. World J Gastroenterol 2011;17:397-402. https://doi.org/10.3748/wjg.v17.i3.397
  28. Marinelli I, Guido A, Fuccio L, et al. Clinical target volume in biliary carcinoma: a systematic review of pathological studies. Anticancer Res 2017;37:955-61. https://doi.org/10.21873/anticanres.11404

Cited by

  1. Benefit of Adjuvant Chemoradiotherapy in Resected Gallbladder Carcinoma vol.9, pp.1, 2017, https://doi.org/10.1038/s41598-019-48099-z
  2. Influence of adjuvant therapy on pattern of failure and survival in curatively resected gallbladder carcinoma vol.17, pp.4, 2017, https://doi.org/10.4103/jcrt.jcrt_550_19
  3. Current update on gallbladder carcinoma vol.46, pp.6, 2021, https://doi.org/10.1007/s00261-020-02871-2